Evidence map›Paper›PMID 11023824›Full record

ArticleThe Biochemical journal2000

Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.

B Herzog, M Waltner-Law, D K Scott, K Eschrich, D K Granner

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Proteomic analysis of fructose-induced fatty liver in hamsters.Metabolism: clinical and experimental · 2008
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B HerzogInstitute of Biochemistry, School of Medicine, University of Leipzig, Liebigstrasse 16, D-04103 Leipzig, Germany.
M Waltner-Law
D K Scott
K Eschrich
D K Granner
Leipzig University · DE

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
INSULIN RECEPTORS AND INSULIN ACTIONR37DK035107 · NIDDK · VANDERBILT UNIVERSITY · PI GRANNER, DARYL K · 1989 to 2005
$4.8M
INSULIN RECEPTORS AND INSULIN ACTIONR01DK035107 · NIDDK · VANDERBILT UNIVERSITY · PI NISWENDER, KEVIN D · 1986 to 2006
$917k
NIDDK NIH HHS DK07563NIDDK NIH HHS DK20593NIDDK NIH HHS DK35107
6 · The paper itself

Abstract

Fructose-1,6-bisphosphatase (FBPase; EC 3.1.3.11), an important gluconeogenic enzyme, catalyses the hydrolysis of fructose 1, 6-bisphosphate to fructose 6-phosphate and P(i). Enzyme activity is mainly regulated by the allosteric inhibitors fructose 2, 6-bisphosphate and AMP. Although some observations about hormonal regulation of the enzyme have been published, the FBPase promoter has not been studied in detail. Here we report an in vitro characterization of the FBPase promoter with respect to the elements that are required for basal promoter activity. Transient transfection of H4IIE rat hepatoma cells, combined with site-directed mutagenesis, demonstrated that an enhancer box, three GC-boxes and a nuclear factor kappaB (NF-kappaB)-binding element are important for hepatic FBPase promoter activity. These elements are found in the region located between -405 to +25 bp relative to the transcription start site. Electrophoretic-mobility-shift assays and supershift analysis confirmed that upstream stimulatory factor 1 (USF1)/USF2, specificity protein 1 (Sp1)/Sp3 and NF-kappaB respectively bind to these sites. The present study provides the basis for a more comprehensive screening for mutations in FBPase-deficient patients and for further studies of the transcriptional regulation of this gene.

Indexed as

Promoter Regions, GeneticAnimalsBase SequenceBinding SitesCarcinoma, HepatocellularCell NucleusDNA-Binding ProteinsElectrophoresisEnhancer Elements, GeneticFructose-BisphosphataseGene DeletionGenes, ReporterHumansHydrolysisLiverMolecular Sequence DataDNA-Binding ProteinsFructose-BisphosphataseNF-kappa BProtein IsoformsSp1 Transcription FactorSP3 protein, humanSp3 protein, ratSp3 Transcription FactorTranscription FactorsUpstream Stimulatory FactorsUSF1 protein, humanUsf1 protein, ratUSF2 protein, humanUsf2 protein, rat

Identifiers

PMID11023824
PMCPMC1221374
OpenAlexW1979947265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.